Skip to content

NBP

NovaBridge Biosciences

NASDAQ · USHealthcareBiotechnology
$1.79+0.56%

Price as of Jul 20, 2026

NBP capital

NovaBridge Biosciences capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.01x
Net debt / equity
-0.90x
Debt / assets
0.01x
Debt / EBITDA
-0.01x
Net debt / EBITDA
0.94x

Liquidity & coverage

Current ratio
8.09x
Quick ratio
8.09x
Cash ratio
7.84x
Interest coverage
EBITDA / interest
Working capital
$27.3M

Cash & dividend

FCF / debt
-3.30x
Cash flow / debt
-3.31x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.